Skip to main content

Therapeutics Startups

Updated August 2026

Companies in the therapeutics sector developing innovative solutions and technologies.

Explore 1,699 recently funded therapeutics companies with verified founder contact information and fundraising data.

Total Companies
1,699
Total Funding
$962.1M
Avg Funding
$38.5M
Global Reach
7
countries

Top Cities for Therapeutics

London
Cambridge
Moorestown
Minnesota City
Florham Park
Seattle

Recently Funded Companies

Export
London, United Kingdom

VIVAN Therapeutics is a company pioneering personalized cancer therapeutics using a new assay technology.

Dec 2022

Founder Contacts

41,000+ verified contacts

Cambridge, United States

CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.

$30.0M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

Moorestown, United States

Cosan is a preventative care coordination tool that helps physicians and healthcare systems.

$15.0M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

Minnesota City, United States

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and proprietary treatments.

$4.0M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

Florham Park, United States

Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies.

$10.0M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

Seattle, United States

Athira Pharma is a clinical stage drug development company that specializes in biotechnology and pharmaceutical.

$90.0M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

Boston, United States

Tiga TX develops an IgA therapeutic monoclonal antibody platform for the treatment of solid tumors.

$35.5M raised
Dec 2024

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

SiteOne Therapeutics develops groundbreaking non-opioid treatments for acute, neuropathic, visceral, and musculoskeletal pain.

$100.0M raised
Dec 2024

Founder Contacts

41,000+ verified contacts

San Francisco, United States

PhyxUp Health provides an AI-powered Remote Therapeutic Monitoring and B2B SaaS platform for physical therapy clinics.

Dec 2025

Founder Contacts

41,000+ verified contacts

Wendelsheim, Germany

MODAG aims to provide a novel approach for treating neurodegenerative diseases by combining targeted small molecule therapeutics.

$1.0M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

Powell, United States

DNA Nanobots is a leader in the design and delivery of DNA nanoparticles tailored for targeted therapies.

$3.5M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

Sevilla, Spain

PlusVitech develops effective and safe therapeutic treatments and complementary diagnostic tests for cancer patients.

$2.9M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Xcell Biosciences is a next-generation development and manufacturing platform for enhanced cell therapy performance.

$1.4M raised
Dec 2024

Founder Contacts

41,000+ verified contacts

Winnetka, United States

Akava Therapeutics is a small molecule therapeutics that inhibits protein aggregation, enzymes, and cancer for neurodegenerative diseases.

$7.3M raised
Dec 2024

Founder Contacts

41,000+ verified contacts

Naarden, The Netherlands

NorthSea Therapeutics is a clinical-stage biotech company developing first-in class, oral, structurally-engineered lipid therapeutics.

$80.0M raised
Dec 2021

Founder Contacts

41,000+ verified contacts

Irvine, United States

Ambros Therapeutics is a clinical-stage biotechnology company.

$125.0M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

Vancouver, Canada

RepliCel Life Sciences is a regenerative medicine company using cell therapy products for healing tendinosis, aging, and pattern baldness.

$224K raised
Dec 2024

Founder Contacts

41,000+ verified contacts

Edinburgh, United Kingdom

Concinnity Genetics transform the safety of gene therapies by designing novel control mechanisms using AI platform.

$3.8M raised
Dec 2024

Founder Contacts

41,000+ verified contacts

Bottmingen, Switzerland

Anaveon is a developing IL-2 complexes which selectively promote effector T cell functions.

$119.7M raised
Dec 2021

Founder Contacts

41,000+ verified contacts

Natick, United States

Attivare Therapeutics is a biotechnology company that develops small-molecule therapies that modulate immune and inflammatory pathways.

$6.6M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

Malvern, United States

MAXONA is a pharmaceutical company that develops and commercializes a portfolio of novel therapeutics for the treatment of pain.

$6.9M raised
Dec 2022

Founder Contacts

41,000+ verified contacts

Basel, Switzerland

Bottneuro develops Digital therapies for Alzheimer's Disease using Electrical stimulation of glia cells in the brain.

$4.3M raised
Dec 2022

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.

$300.0M raised
Dec 2021

Founder Contacts

41,000+ verified contacts

Headington, United Kingdom

Alethiomics is a biotech company harnessing the power of single-cell multi-omic technology to discover & develop treatment for blood cancer.

$8.0M raised
Dec 2021

Founder Contacts

41,000+ verified contacts

Montréal, Canada

Valence Discovery (“Valence”), is an AI-first design of novel chemistry against previously intractable biology.

$7.0M raised
Dec 2021

Founder Contacts

41,000+ verified contacts

Showing 1351 to 1375 of 1,699 companies

About the Therapeutics Startup Ecosystem

The therapeutics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Therapeutics

Therapeutics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The therapeutics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Therapeutics Funding Breakdown

Here is how funding is distributed among the 1,699 therapeutics companies tracked in the VCBacked database.

Average Funding
$38.5M
Total Funding Tracked
$962.1M
Countries Represented
7

Distribution by Funding Stage

Other25 companies

Top Cities for Therapeutics

1.South San Francisco
2 companies$400.0M
2.San Francisco
2 companies$1.4M
3.London
1 companiesUndisclosed
4.Cambridge
1 companies$30.0M
5.Moorestown
1 companies$15.0M

Related Industries

Companies in the therapeutics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Therapeutics Startups?

Perfect for: B2B sales teams targeting therapeutics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked